(2019). Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
Chicago Style (17th ed.) CitationNontherapeutic Equivalence of a Generic Product of Imipenem-cilastatin Is Caused More by Chemical Instability of the Active Pharmaceutical Ingredient (imipenem) than by Its Substandard Amount of Cilastatin. 2019.
MLA (8th ed.) CitationNontherapeutic Equivalence of a Generic Product of Imipenem-cilastatin Is Caused More by Chemical Instability of the Active Pharmaceutical Ingredient (imipenem) than by Its Substandard Amount of Cilastatin. 2019.
Warning: These citations may not always be 100% accurate.